Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02139397
Title Study of DFMO in Combination With Bortezomib for Relapsed or Refractory Neuroblastoma
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Giselle Sholler
Indications

neuroblastoma

Therapies

Eflornithine

Bortezomib

Age Groups: child
Covered Countries USA


No variant requirements are available.